BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 6148873)

  • 1. Atenolol, nadolol, and pindolol in angina pectoris on effort: effect of pharmacokinetics.
    Kostis JB; Lacy CR; Krieger SD; Cosgrove NM
    Am Heart J; 1984 Oct; 108(4 Pt 2):1131-6. PubMed ID: 6148873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-blocker duration of action and implications for therapy.
    Kostis JB
    Am J Cardiol; 1990 Nov; 66(16):60G-62G. PubMed ID: 1978546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the duration of action of atenolol and nadolol for treatment of angina pectoris.
    Kostis JB
    Am J Cardiol; 1988 Dec; 62(17):1171-5. PubMed ID: 3057850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of partial agonist activity in beta blockers in severe angina pectoris: a double blind comparison of pindolol and atenolol.
    Quyyumi AA; Wright C; Mockus L; Fox KM
    Br Med J (Clin Res Ed); 1984 Oct; 289(6450):951-3. PubMed ID: 6148991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term benefit of cardioselective beta blockade with once-daily atenolol therapy in angina pectoris.
    Schwartz JB; Jackson G; Kates RE; Harrison DC
    Am Heart J; 1981 Apr; 101(4):380-5. PubMed ID: 6111212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antianginal effects of atenolol and pindolol in patients with stable effort angina pectoris.
    Antalóczy Z; Kekes E
    Zhongguo Yao Li Xue Bao; 1989 May; 10(3):222-6. PubMed ID: 2609991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nadolol compared to propranolol for treating chronic stable angina pectoris.
    Miller LA; Crawford MH; O'Rourke RA
    Chest; 1984 Aug; 86(2):189-93. PubMed ID: 6146499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between atenolol and nadolol in essential hypertension at rest and on exercise.
    Wilcox RG; Hampton JR
    Br J Clin Pharmacol; 1982 Jun; 13(6):841-6. PubMed ID: 6124268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacodynamics of the new beta blockader corgard (nadolol) in patients with stress-induced angina pectoris].
    Nikolenko SA; Metelitsa VI; Nazarenko VA; Martsevich SIu; Kulikova TV
    Kardiologiia; 1984 Feb; 24(2):14-8. PubMed ID: 6143849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atenolol: once-daily cardioselective beta blockade for angina pectoris.
    Jackson G; Schwartz J; Kates RE; Winchester M; Harrison DC
    Circulation; 1980 Mar; 61(3):555-60. PubMed ID: 6243518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of the action of a series of new beta-adrenergic receptor blockaders in patients with effort angina].
    Romakov AIu; Sagirov AM; Desiatnichenko VM; Sobol' IuS; Sumarokov AB
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):57-63. PubMed ID: 6139118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of ancillary properties of beta blockers in angina: a study of celiprolol and atenolol.
    McLenachan JM; Wilson JT; Dargie HJ
    Br Heart J; 1988 Jun; 59(6):685-9. PubMed ID: 2899439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical, cardio- and hemodynamic effects of long- and short-acting beta-adrenergic blockers in the treatment of patients with stable stenocardia].
    Ol'binskaia LI; Bragina GI
    Kardiologiia; 1984 Apr; 24(4):9-13. PubMed ID: 6727119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celiprolol and atenolol in angina--effects on left ventricular function.
    Dargie H; McLenachan JM; Wilson JT
    J Int Med Res; 1988; 16 Suppl 1():47A-51A. PubMed ID: 2906017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative review of beta-blocking agents.
    Jackson EA; Sullman SA
    Conn Med; 1984 Apr; 48(4):213-5. PubMed ID: 6143648
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of bopindolol and atenolol in chronic stable angina pectoris.
    Fitscha P; Meisner W; Tiso B
    Eur J Clin Pharmacol; 1990; 38(1):81-4. PubMed ID: 1970300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of nadolol, a new long-acting beta-receptor blocking agent, and placebo in the treatment of stable angina pectoris.
    Shapiro W; Park J; DiBianco R; Singh SN; Katz RJ; Fletcher R
    Chest; 1981 Oct; 80(4):425-30. PubMed ID: 6791883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of bevantolol and atenolol in chronic stable angina.
    Rodrigues EA; Lawrence JD; Dasgupta P; Hains AD; Lahiri A; Wilkinson PR; Raftery EB
    Am J Cardiol; 1988 Jun; 61(15):1204-9. PubMed ID: 2897780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atenolol in the treatment of angina pectoris.
    Erikssen J; Osvik K; Dedichen J
    Acta Med Scand; 1977; 201(6):579-84. PubMed ID: 17996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.